Search Count: 1,732
 |
Crystal Structure Of Human Sirt2 In Complex With A Pyrazole-Based Fragment Inhibitor And Nad+
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-06-04 Classification: HYDROLASE Ligands: ZN, EDO, DMS, NAD, A1IBW |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: ZN, DMS, PG4, EDO, PEG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: ZN, CL, DMS, EDO, 3TE |
 |
Crystal Structure Of Human Sirt2 In Complex With A Pyrazole-Based Fragment Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: ZN, CL, DMS, EDO, A1IBW |
 |
Crystal Structure Of Human Sirt2 In Complex With A Pyridine-3-Carbothioamide-Based Fragment Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: ZN, CL, DMS, EDO, A1IBX |
 |
Crystal Structure Of Human Sirt2 In Complex With A 3-Chlorobenzamide-Based Fragment Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: A1IBY, DMS, EDO, ZN |
 |
Crystal Structure Of Human Sirt2 In Complex With The Peptide-Based Inhibitor Kt9
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2025-05-28 Classification: HYDROLASE Ligands: ZN, DMS, EDO, A1IBZ |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment B05 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, A1BVZ, NA |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment B08 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: T9S, DMS |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment C02 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, SYA, NA, DMS |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment C07 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, VN9, DMS |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment C10 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, TJV, DMS, NA |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment D04 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: R9D, DMS, CL |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment D08 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, A1BVW, NA, DMS |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment D11 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, R9M, NA, DMS |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment E11 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, RA7 |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment F04 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, RB7, DMS, NA |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment G03 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, RD4, NA |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment G04 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, DMS, NA, T9V |
 |
Pandda Analysis Group Deposition -- Main Protease (Sars-Cov-2) In Complex With Fragment G09 From The F2X-Entry Screen In Orthorhombic Space Group
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2025-05-21 Classification: VIRAL PROTEIN Ligands: CL, RDM, DMS, NA |